Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Haemonetics Corp (HAE)

Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
1 Value Stock on Our Buy List and 2 Facing Headwinds

1 Value Stock on Our Buy List and 2 Facing Headwinds

COLL : 34.31 (-0.29%)
HAE : 61.17 (-0.73%)
WT : 18.30 (+4.81%)
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2026 Results: May 7, 2026

BOSTON , April 1, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter fiscal year 2026 financial results at 6:00 am ET on Thursday,...

HAE : 61.17 (-0.73%)
Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System

VASCADE MVP XL now approved for larger sheaths used in market-leading PFA and LAAC technologies

HAE : 61.17 (-0.73%)
3 Small-Cap Stocks That Fall Short

3 Small-Cap Stocks That Fall Short

WERN : 33.50 (+2.82%)
HHH : 67.45 (+2.29%)
HAE : 61.17 (-0.73%)
2 Healthcare Stocks with Solid Fundamentals and 1 Facing Challenges

2 Healthcare Stocks with Solid Fundamentals and 1 Facing Challenges

ZTS : 122.72 (+0.71%)
HAE : 61.17 (-0.73%)
ELV : 319.36 (-1.14%)
A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q4 Earnings: Haemonetics (NYSE:HAE) Vs The Rest Of The Pack

A Look Back at Medical Devices & Supplies - Specialty Stocks’ Q4 Earnings: Haemonetics (NYSE:HAE) Vs The Rest Of The Pack

HAE : 61.17 (-0.73%)
3 Reasons HAE is Risky and 1 Stock to Buy Instead

3 Reasons HAE is Risky and 1 Stock to Buy Instead

HAE : 61.17 (-0.73%)
3 Profitable Stocks with Open Questions

3 Profitable Stocks with Open Questions

ASGN : 40.04 (+1.52%)
GPC : 112.59 (-1.05%)
HAE : 61.17 (-0.73%)
Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology

BOSTON , Feb. 23, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today...

HAE : 61.17 (-0.73%)
Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference

BOSTON , Feb. 20, 2026 /PRNewswire/ --  Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James...

HAE : 61.17 (-0.73%)

Barchart Exclusives

As Costco Raises Its Dividend More Than 13%, Should You Buy, Sell, or Hold COST Stock?
Costco raised its quarterly dividend 13.1% to $1.47 per share. Here's what investors need to know before deciding to buy, sell, or hold COST stock right now. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.